UBS Group’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
UBS Group's STE Position: Q3 2026 in Review
UBS Group increased its Steris (STE) stake by 17% in Q3 2026, buying an estimated $15.3M and bringing the position to 466,002 shares worth $97.9M. The position accounts for 0.01% of the portfolio, ranked #1112.
UBS Group first reported a position in STE in Q4 2014 and has held it in 48 quarters since. The position peaked at $130M in Q4 2025. 820 funds tracked by Wall St. Rank hold STE as of Q3 2026.
- UBS Group held 466,002 shares of Steris worth $97.9M as of Q3 2026.
- UBS Group bought 69,001 Steris shares in Q3 2026, an estimated $15.3M.
- Steris made up 0.01% of UBS Group's portfolio in Q3 2026, its #1112 holding.
- UBS Group first reported a position in Steris in Q4 2014 and has held it in 48 quarters since.
- UBS Group's Steris position peaked at $130M in Q4 2025.
- 820 funds tracked by Wall St. Rank held Steris as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.